Children’s Hospital of Philadelphia (CHOP), in partnership with the Philadelphia Housing Development Corporation (PHDC), announced a new Community Asthma Prevention Program Plus (CAPP+) Home Repairs Program, developed to address the impact of unhealthy housing on pediatric asthma outcomes in West Philadelphia neighborhoods. CAPP+ is the pilot initiative of Healthier Together, […]
Patient Care
Collaborative Summit Explores Models to Improve Sleep Apnea Patient Care
Representatives from 14 medical and patient groups discuss diagnostic and treatment pathways In Chicago on Saturday, Nov. 10, the American Academy of Sleep Medicine (AASM) hosted 35 representatives from 14 medical associations and patient advocacy groups for a one-day Sleep-Disordered Breathing Collaboration Summit to discuss strategies to improve the diagnosis […]
Historic UN High-Level Meeting on TB
The UN High-Level Meeting (HLM) on Tuberculosis will take place today at the United Nations in New York. This will be the UN General Assembly’s first-ever meeting to accelerate efforts against this disease. The ATS calls on all countries, including the United States, to commit to ending TB at this […]
New Guideline Aids in Diagnosing Idiopathic Pulmonary Fibrosis
A new international guideline has been developed to help physicians diagnosis idiopathic pulmonary fibrosis (IPF), a rare and often fatal lung disease whose cause is unknown. The 2018 clinical practice guideline was developed by experts representing four major respiratory societies—the American Thoracic Society (ATS), the European Respiratory Society (ERS), Japanese […]
2018’s Best & Worst States for Health Care
With the Affordable Care Act remaining in effect and the CDC reporting that over 88 percent of the population has a regular place to go for medical care, the personal-finance website WalletHub today released its report on 2018’s Best & Worst States for Health Care as well as accompanying videos. In order to […]
FDA Approves ORKAMBI®, First Medicine to Treat the Underlying Cause of CF for Children Ages 2-5 Years with Most Common Form of the Disease
Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) has approved ORKAMBI® (lumacaftor/ivacaftor) to include use in children ages 2 through 5 years with cystic fibrosis (CF) who have two copies of the F508del-CFTR mutation, making it the first medicine approved to treat the underlying cause of CF […]
Philips Celebrates World Sleep Day Early: Annual Global Sleep Survey Results, Overnight Concert
Philips celebrates World Sleep Day early with the release of its annual global sleep survey results, overnight concert experience • Survey finds that 77 percent of global adults have actively taken steps to improve their sleep, with listening to soothing music revealed as one of the most prominent […]
Elucidation: Explain it – Part I
By Kaye Prather Imagine you’re unwell—it’s not hard to do. You’ve been through all kinds of tests, been poked and prodded and medicated. Everyone seems to be speaking Clinicalese, not English. You want to know what’s wrong and whether it can be fixed or if you have to learn to […]
Amazon, Berkshire Hathaway, JPMorgan to Form Healthcare Company
Amazon, Berkshire Hathaway and JPMorgan Chase & Co. announced that they are partnering on ways to address healthcare for their U.S. employees, with the aim of improving employee satisfaction and reducing costs. The three companies, which bring their scale and complementary expertise to this long-term effort, will pursue this objective […]
Saying “Just Relax” Is Not Enough
By Kaye Prather, RRT-NPS, AE-C Imagine for a minute you’re the person in a classic Dudley Do-Right cartoon. You are tied to a railroad track. The train is coming, you can feel the vibration of the rails. You can see the train in the distance and your heart starts pounding. […]













